Kyruus Raises $11M Series B to Accelerate the Rapid Growth of its Physician Network Management Solutions

Boston, MA -- 01/02/13
Back To Press & Events

Boston, MA, January 2, 2013 – Kyruus, a leading healthcare Big Data company, today announced the closing of an $11M Series B financing. The investment was led by Lux Capital, with participation from Fidelity Biosciences as well as existing investors Venrock and Highland Capital Partners. The financing brings the total amount raised by Kyruus to $19.6M since its inception in 2010.

“We are delighted to partner with Lux and Fidelity as we enter the next phase of our company’s growth,” said Graham Gardner, CEO of Kyruus. “Both firms bring important relationships with large numbers of healthcare organizations that today wrestle with how to understand and engage their physician networks. We believe our applications can transform the way these organizations coordinate physician expertise and optimize the delivery of patient care.”

Over the last year, Kyruus has quickly established a customer base of over 20 leading healthcare organizations from across the country, ranging from community hospitals to large multi-facility health systems. The company’s product platform enables organizations to optimize the performance of their physician networks across the areas of network development, referral management, and regulatory compliance. Kyruus will use the new funds to expand its sales and marketing efforts across each of these solution areas.

In conjunction with the financing, Robert Paull, Managing General Partner at Lux Capital, will join the Kyruus Board of Directors. “Large healthcare organizations are by nature extraordinarily complex,” said Paull. “Kyruus solves difficult data problems – providing customers with the clarity to make more informed decisions. Lux is excited to help a remarkable group of entrepreneurs build a defining healthcare information company.”

Share On Twitter Linkedin